The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis
Surasi DSS, Wang X, Bathala TK, Hwang H, Arora S, Westphalen AC, Chang SD, Turkbey B. The impact and collateral damage of COVID-19 on prostate MRI and guided biopsy operations: Society of Abdominal Radiology Prostate Cancer Disease-Focused Panel survey analysis. Abdominal Radiology 2021, 46: 4362-4369. PMID: 33904992, PMCID: PMC8077193, DOI: 10.1007/s00261-021-03087-8.Peer-Reviewed Original ResearchConceptsBowel preparationMedian numberProstate MRICoronavirus disease 2019 (COVID-19) pandemicCOVID-19Disease 2019 pandemicCOVID-19 pandemicHealth care systemComplete responseMedical oncologyProstate biopsyClinic schedulesProstate cancerMRI studiesLockdown periodCare systemCollateral damageRadiation oncologyClinical departmentsPanel survey analysisMRIBiopsyRadiology departmentOncologyDescriptive statisticsMR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer
Galgano SJ, Planz VB, Arora S, Rais-Bahrami S. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer. Current Urology Reports 2021, 22: 3. PMID: 33403460, DOI: 10.1007/s11934-020-01020-y.Peer-Reviewed Original ResearchConceptsTreatment modalitiesProstate cancerFocal therapyFavorable side effect profileLong-term oncologic outcomesSide effect profileMR-Guided HighNovel treatment modalitiesPromising early resultsProstate cancer diagnosisOncologic outcomesDefinitive treatmentUrinary sphincterNeurovascular bundleRadical prostatectomyActive surveillanceRadiation therapyFocal ablationHeterogeneous diseaseProstate glandReviewThe goalTherapyUltrasound ablationCancer diagnosisProstate MRI